Neopharm Life Science Ventures (NLSV) conceives, incubates, and supports pharmaceutical and biotechnology enterprises.
NLSV’s mission is to identify life-science technologies and product companies that have the potential to transform global healthcare by providing innovative solutions to medical practices.
NLSV offers added value through its active management and support of portfolio enterprises as carried out by a core team of experienced life science professionals.
NLSV helps to bridge the gap from early discovery to initial clinical proof-of-concept, working with global strategic partners for clinical registration, marketing, and distribution.
NLSV’s lead program is focused on the development of innovative therapies, which positively transform the lives of patients suffering from rare, life-threatening diseases with unmet medical needs.
NLSV continuously seeks in-licensing opportunities from both the academic and private sectors. The division specializes in seeking out products with a defined mechanism of action, which provides a competitive advantage for conditions with unmet medical need.